Chinook Tyee Industry Limited (TSXV: XCX) Jumps 44% After Closing C$1.5 Million Series A Private Placement Offering

Chinook Tyee Industry Limited (TSXV: XCX) is a Germany-based investment company, which holds two European subsidiaries: AMP Alternative Medical Products & Mercury Partners & Company Plc. AMP imports pharmaceuticals-grade cannabis from Canadian licensed producers to Germany. AMP provides EU-GMP audit, logistics, transport, and import services for medical cannabis coming into Germany. Mercury Partners & Company Plc is a Malta-based investment…

Read More

Marijuana Stocks Are Tumbling: Here’s What You Should Buy

There was a slight hiccough last week within the cannabis industry. While it didn’t come from Canada, it definitely could put a damper on things for cannabis companies that are seeking to expand through the United States. Last week the Food and Drug Administration (FDA) said in its first set of hearings that it would need more information now that…

Read More

Is Colombia Poised to Become the Saudi Arabia of Cannabis?

The strife-torn South American nation of Colombia has embarked on an ambitious undertaking to reinvigorate its weak economy and reduce its dependence on oil by becoming a leading global producer of medical marijuana products. For a wide variety of reasons, this may not be as daunting as it seems. Colombia, by virtue of its equatorial climate and natural diversity, possesses…

Read More

EnerDynamic Hybrid Technologies Corp. (TSXV: EHT) Rallies 25% After Application to Grow Medical Cannabis

EnerDynamic Hybrid Technologies Corp.

EnerDynamic Hybrid Technologies Corp. (TSXV: EHT) is engaged within the development of turn-key energy efficiency and smart energy solutions. Shares of the energy solutions provider are rallying 25%, through afternoon trading on Thursday, April 25, 2019. Over the past three months, EnerDynamic Hybrid Technologies has seen average daily volume of 843,036 shares. However, volume of 3.38 million shares or dollar…

Read More

Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone

Resverlogix Corp.

BETonMACE trial to continue as planned without modification CALGARY, Alberta, March 27, 2019 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) today announces the independent Data and Safety Monitoring Board (DSMB) has completed a ninth planned safety review for the Company’s Phase 3, BETonMACE trial for high-risk cardiovascular disease patients and recommended the study continue without modification. The…

Read More

Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children

Collaboration with SRI Provides QBioMed Expertise in Formulation Development and Preclinical Work in Autism, as well as CMC and Manufacturing capability NEW YORK, December 12, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001, in support…

Read More

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™,…

Read More